Phase 3 trial of SMS 201-995 pa LAR (SMS pa LAR) and continuous infusion (CI) 5-FU in unresectable stage II, III, and IV pancreatic cancer

収録刊行物

• American Society Clinical Oncology in Los Angeles, May 1998

  American Society Clinical Oncology in Los Angeles, May 1998 1998